BUSINESS● LOW1h ago · Oct 27, 2026, 3:32 PM
Kiniksa targets $1.045B-$1.050B 2026 revenue as KPL-387 data expected in H2 2027
Seeking Alpha Tech · north america
Kiniksa Pharmaceuticals is targeting between $1.045 billion and $1.050 billion in revenue by 2026, with data for its KPL-387 product anticipated in the second half of 2027. This outlines the company's financial projections and key development milestones.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowDesalination and hydrogen: the great green transformation of Moroccan OCPJeune AfriqueBUSINESS14m agoRestructuring of the board of directors and suspicions of conflicts of interest: what's happening at Ecobank?Jeune Afrique